your market intelligence analyst
Search Results
430 results
Your search is now limited to «Merck» expert search.
3BL Media 07/22/2019 10:00
For the fifth year in a row, Merck was recognized as a Best Places to Work for Disability Inclusion, receiving a score of 100% on the 2019 Disability Equality Index (DEI.
More from 3BL Media: 07/22/2019 08:26
According to a newly published report by, “Worldwide Rotavirus Vaccines Market: Information About Key Drivers, Restraints, And Opportunities 2019-2029“. The prime objective of the report is to deliver a Ten-year (2019-2029) market forecast. The latest study focusing on rotavirus vaccines market with topmost companies, to determine, define and analyses the sales size, value, market share, market competition landscape, and recent development. It helps to decide a corporate, product, mark…
More from
FierceMedicalDevices 07/22/2019 08:17
The candidate uses a drug delivery system designed to improve on Merck’s Sinemet but was unable to beat the established product in a late-phase test.
More from FierceMedicalDevices: (India) 07/19/2019 18:09
Merck Foundation also plans to introduce other unique initiatives in the country to create the desired culture shift with regard to breaking the stigma around infertility.
More from (India):
Seeking Alpha 07/19/2019 12:12
Livongo Health, Inc. uses artificial intelligence and data science to improve the quality of life of patients suffering from chronic diseases. Livongo Health ob.
More from Seeking Alpha: 07/19/2019 06:15
Merck and the Broad Institute of MIT and Harvard (Boston, Massachusetts) announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product development.
More from
FDLI SmartBrief 07/18/2019 11:52
Merck's antibacterial drug Recarbrio, or imipenem, cilastatin and relebactam, gained FDA approval as a treatment for complicated intra-abdominal infections and complicated urinary tract infections in adults.
More from FDLI SmartBrief:
STAT 07/18/2019 09:44
The FDA approved a combination antibiotic treatment called Recarbio from Merck for complicated forms of urinary tract and abdominal infections.
More from STAT:
PR Newswire 07/18/2019 08:00
DARMSTADT, Alemania, 18 de julio de 2019 /PRNewswire/ -- Merck, empresa líder de ciencia y tecnología, y el Instituto Broad del Instituto de Tecnología de Massachusetts (MIT) y Harvard (Boston, Massachusetts) anunciaron hoy un acuerdo para ofrecer licencias no exclusivas sobre propiedad...
More from PR Newswire:
FDA approves Merck’s Recarbrio to treat complicated infections.
More from Pharmaceutical Business Review:
BioPharma Dive 07/17/2019 11:46
To develop Recarbrio, Merck added relebactam to an imipenem/cilastin combination that Merck already markets as Primaxin.
More from BioPharma Dive:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications